
Robert W. Downs
Examiner (ID: 17152)
| Most Active Art Unit | 2308 |
| Art Unit(s) | 2762, 4762, 2309, 2308, 2165 |
| Total Applications | 581 |
| Issued Applications | 448 |
| Pending Applications | 24 |
| Abandoned Applications | 109 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 12001813
[patent_doc_number] => 20170305968
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-10-26
[patent_title] => 'PEPTIDES WHOSE UPTAKE IN CELLS IS CONTROLLABLE'
[patent_app_type] => utility
[patent_app_number] => 15/427427
[patent_app_country] => US
[patent_app_date] => 2017-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 49
[patent_figures_cnt] => 49
[patent_no_of_words] => 43987
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15427427
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/427427 | PEPTIDES WHOSE UPTAKE IN CELLS IS CONTROLLABLE | Feb 7, 2017 | Abandoned |
Array
(
[id] => 11742922
[patent_doc_number] => 20170196995
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-07-13
[patent_title] => 'OPTICAL IMAGING PROBES'
[patent_app_type] => utility
[patent_app_number] => 15/413139
[patent_app_country] => US
[patent_app_date] => 2017-01-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 13421
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15413139
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/413139 | Optical imaging probes | Jan 22, 2017 | Issued |
Array
(
[id] => 16492371
[patent_doc_number] => 10858396
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-12-08
[patent_title] => HER2 peptide regents and methods
[patent_app_type] => utility
[patent_app_number] => 15/780286
[patent_app_country] => US
[patent_app_date] => 2016-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 97
[patent_no_of_words] => 14060
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15780286
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/780286 | HER2 peptide regents and methods | Nov 30, 2016 | Issued |
Array
(
[id] => 16930953
[patent_doc_number] => 20210196842
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-01
[patent_title] => SITE-SPECIFIC RADIOFLUORINATION OF PEPTIDES WITH 8-[18F]-FLUOROOCTANOIC ACID CATALYZED BY LIPOIC ACID LIGASE
[patent_app_type] => utility
[patent_app_number] => 15/777558
[patent_app_country] => US
[patent_app_date] => 2016-11-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24861
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 87
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15777558
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/777558 | SITE-SPECIFIC RADIOFLUORINATION OF PEPTIDES WITH 8-[18F]-FLUOROOCTANOIC ACID CATALYZED BY LIPOIC ACID LIGASE | Nov 28, 2016 | Abandoned |
Array
(
[id] => 18908935
[patent_doc_number] => 11871895
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-01-16
[patent_title] => Raman spectroscopy reporters and methods for molecular imaging of tissue in vivo
[patent_app_type] => utility
[patent_app_number] => 15/778236
[patent_app_country] => US
[patent_app_date] => 2016-11-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 10
[patent_no_of_words] => 5342
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15778236
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/778236 | Raman spectroscopy reporters and methods for molecular imaging of tissue in vivo | Nov 22, 2016 | Issued |
Array
(
[id] => 13567775
[patent_doc_number] => 20180335435
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-11-22
[patent_title] => USE OF RECEPTOR-BINDING DOMAIN DERIVED FROM BOVINE LEUKEMIA VIRUS FOR THE DIAGNOSIS OR TREATMENT OF CATIONIC L-AMINO ACID TRANSPORTER-RELATED DISEASES
[patent_app_type] => utility
[patent_app_number] => 15/777087
[patent_app_country] => US
[patent_app_date] => 2016-11-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16481
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15777087
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/777087 | Use of receptor-binding domain derived from bovine leukemia virus for the diagnosis or treatment of cationic l-amino acid transporter-related diseases | Nov 17, 2016 | Issued |
Array
(
[id] => 11689666
[patent_doc_number] => 20170165382
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-06-15
[patent_title] => 'NANOCARRIERS FOR CANCER TREATMENT'
[patent_app_type] => utility
[patent_app_number] => 15/349946
[patent_app_country] => US
[patent_app_date] => 2016-11-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 20241
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15349946
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/349946 | NANOCARRIERS FOR CANCER TREATMENT | Nov 10, 2016 | Abandoned |
Array
(
[id] => 13604159
[patent_doc_number] => 20180353628
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-12-13
[patent_title] => Labeled Probe and Methods of Use
[patent_app_type] => utility
[patent_app_number] => 15/775450
[patent_app_country] => US
[patent_app_date] => 2016-11-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11561
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15775450
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/775450 | Labeled probe and methods of use | Nov 10, 2016 | Issued |
Array
(
[id] => 13604157
[patent_doc_number] => 20180353627
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-12-13
[patent_title] => RADIOLABELED DISINTEGRINS AS BRACHYTHERAPY AGENTS
[patent_app_type] => utility
[patent_app_number] => 15/775743
[patent_app_country] => US
[patent_app_date] => 2016-11-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10695
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15775743
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/775743 | RADIOLABELED DISINTEGRINS AS BRACHYTHERAPY AGENTS | Nov 10, 2016 | Abandoned |
Array
(
[id] => 11671567
[patent_doc_number] => 20170160287
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-06-08
[patent_title] => 'USE OF 7-CHLORO-N,N,5-TRIMETHYL-4-OXO-3-PHENYL-3,5-DIHYDRO-4H-PYRIDAZINO[4,5-B] INDOLE-1-ACETAMIDE AS A BIOMARKER OF PERIPHERAL BENZODIAZEPINE RECEPTOR LEVELS'
[patent_app_type] => utility
[patent_app_number] => 15/347965
[patent_app_country] => US
[patent_app_date] => 2016-11-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 10993
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15347965
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/347965 | USE OF 7-CHLORO-N,N,5-TRIMETHYL-4-OXO-3-PHENYL-3,5-DIHYDRO-4H-PYRIDAZINO[4,5-B] INDOLE-1-ACETAMIDE AS A BIOMARKER OF PERIPHERAL BENZODIAZEPINE RECEPTOR LEVELS | Nov 9, 2016 | Abandoned |
Array
(
[id] => 11443059
[patent_doc_number] => 20170044080
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-02-16
[patent_title] => 'RADIOCONJUGATION METHOD'
[patent_app_type] => utility
[patent_app_number] => 15/340743
[patent_app_country] => US
[patent_app_date] => 2016-11-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9068
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15340743
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/340743 | RADIOCONJUGATION METHOD | Oct 31, 2016 | Abandoned |
Array
(
[id] => 13339919
[patent_doc_number] => 20180221499
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-09
[patent_title] => SSTR-TARGETED CONJUGATES AND PARTICLES AND FORMULATIONS THEREOF
[patent_app_type] => utility
[patent_app_number] => 15/770513
[patent_app_country] => US
[patent_app_date] => 2016-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35511
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -44
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15770513
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/770513 | SSTR-targeted conjugates and particles and formulations thereof | Oct 27, 2016 | Issued |
Array
(
[id] => 11647950
[patent_doc_number] => 20170143851
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-05-25
[patent_title] => 'IMAGING AGENTS FOR IMAGING PROTEASE ACTIVITY AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/337461
[patent_app_country] => US
[patent_app_date] => 2016-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 29
[patent_no_of_words] => 13002
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15337461
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/337461 | Imaging agents for imaging protease activity and uses thereof | Oct 27, 2016 | Issued |
Array
(
[id] => 11436228
[patent_doc_number] => 20170037248
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-02-09
[patent_title] => 'FLUORINATED RESORUFIN COMPOUNDS AND THEIR APPLICATION'
[patent_app_type] => utility
[patent_app_number] => 15/299841
[patent_app_country] => US
[patent_app_date] => 2016-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 29974
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15299841
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/299841 | FLUORINATED RESORUFIN COMPOUNDS AND THEIR APPLICATION | Oct 20, 2016 | Abandoned |
Array
(
[id] => 11434894
[patent_doc_number] => 20170035915
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-02-09
[patent_title] => 'FLUORESCENT CONJUGATES'
[patent_app_type] => utility
[patent_app_number] => 15/297975
[patent_app_country] => US
[patent_app_date] => 2016-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 13097
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15297975
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/297975 | Fluorescent conjugates | Oct 18, 2016 | Issued |
Array
(
[id] => 16642096
[patent_doc_number] => 10919932
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-02-16
[patent_title] => Bi-terminal pegylated integrin-binding peptides and methods of use thereof
[patent_app_type] => utility
[patent_app_number] => 15/292564
[patent_app_country] => US
[patent_app_date] => 2016-10-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 30
[patent_no_of_words] => 37086
[patent_no_of_claims] => 46
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 82
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15292564
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/292564 | Bi-terminal pegylated integrin-binding peptides and methods of use thereof | Oct 12, 2016 | Issued |
Array
(
[id] => 13193855
[patent_doc_number] => 10111828
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-10-30
[patent_title] => Treatment and composition for achieving skin anti-aging benefits by corneum protease activation
[patent_app_type] => utility
[patent_app_number] => 15/284158
[patent_app_country] => US
[patent_app_date] => 2016-10-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8252
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15284158
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/284158 | Treatment and composition for achieving skin anti-aging benefits by corneum protease activation | Oct 2, 2016 | Issued |
Array
(
[id] => 11394001
[patent_doc_number] => 20170014536
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-01-19
[patent_title] => 'TIN-117M SOMATOSTATIN RECEPTOR BINDING COMPOUNDS AND METHODS'
[patent_app_type] => utility
[patent_app_number] => 15/280062
[patent_app_country] => US
[patent_app_date] => 2016-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 2805
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15280062
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/280062 | Tin-117m somatostatin receptor binding compounds and methods | Sep 28, 2016 | Issued |
Array
(
[id] => 11422752
[patent_doc_number] => 20170030896
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-02-02
[patent_title] => 'METHOD FOR INDUCING PHYSIOLOGICAL ADJUSTMENT USING HIGH DENSITY DISPLAY OF MATERIAL'
[patent_app_type] => utility
[patent_app_number] => 15/276654
[patent_app_country] => US
[patent_app_date] => 2016-09-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 15673
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15276654
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/276654 | METHOD FOR INDUCING PHYSIOLOGICAL ADJUSTMENT USING HIGH DENSITY DISPLAY OF MATERIAL | Sep 25, 2016 | Abandoned |
Array
(
[id] => 13440931
[patent_doc_number] => 20180272008
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-09-27
[patent_title] => NANOALLERGENS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 15/762260
[patent_app_country] => US
[patent_app_date] => 2016-09-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22451
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15762260
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/762260 | Nanoallergens and uses thereof | Sep 25, 2016 | Issued |